MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.psychres.2022.114975

Медицинская библиотека · Psychiatry research · 2022

Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: A randomized controlled trial.

Garcia Aurora, Yáñez Aina M, Bennasar-Veny Miquel, Navarro Capilla, Salva Joan, Ibarra Olga, Gomez-Juanes Rocío, Serrano-Ripoll María J, Oliván Bárbara, Gili Margalida, Roca Miquel, Riera-Serra Pau, Aguilar-Latorre Alejandra, Montero-Marin Jesús, Garcia-Toro Mauro

Рандомизированное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The high prevalence of depression is partly attributable to the poor response of patients to first-line antidepressants. Multimodal programs that promote a healthy lifestyle are successful in treating depression when used as a complementary therapy, but their medium- and long-term benefits have not been demonstrated for patients with treatment-resistant depression (TRD). The main aim of this study was to compare the effectiveness of a lifestyle modification program (LMP) with mindfulness-based cognitive therapy (MBCT) and a placebo-control (written suggestions for lifestyle changes) in Spanish patients with TRD.

METHODS

This controlled clinical trial randomized 94 patients with TRD into 3 arms. The primary outcome was the Beck Depression Inventory-II (BDI-II) score at baseline, 2, 6 and 12 months. The secondary outcomes were changes in scores that evaluated quality-of-life, adherence to the Mediterranean diet, physical activity, and social support.

RESULTS

Relative to the placebo group, the LMP and MBCT groups had significantly better quality of life (p = 0.017; p = 0.027), and the LMP group had significantly better adherence to the Mediterranean diet (p<0.001) and reduced use of antidepressants (p = 0.036). However, the three groups showed no significant differences in BDI-II score.

LIMITATIONS: Only about half of the planned 180 patients were recruited, in part due to the COVID-19 pandemic.

CONCLUSIONS

There was no evidence that the LMP treatment significantly reduced symptoms of depression relative to the other groups during the COVID-19 lockdown.

Для цитирования: Garcia Aurora, Yáñez Aina M, Bennasar-Veny Miquel, Navarro Capilla, Salva Joan, Ibarra Olga, Gomez-Juanes Rocío, Serrano-Ripoll María J, Oliván Bárbara, Gili Margalida, Roca Miquel, Riera-Serra Pau, Aguilar-Latorre Alejandra, Montero-Marin Jesús, Garcia-Toro Mauro. Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: A randomized controlled trial.. Psychiatry research. 2022. DOI: 10.1016/j.psychres.2022.114975.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.